NEW YORK (GenomeWeb) – In April, at the Clinical Virology Symposium in Daytona Beach, Florida, researchers from the US Centers for Disease Control and Prevention presented a small, preliminary evaluation of three commercial assays for Middle East Respiratory Syndrome coronavirus, also called MERS or MERS-CoV.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.